The abstract is read at the publisher; the summary is JClub's.
HuR (ELAVL1) is enriched in human pancreatic ductal adenocarcinoma and negatively correlates with T-cell infiltration, and HuR loss enhances T-cell number and function in PDAC models.
- Why it matters: PDAC immune evasion is linked to impaired effector T-cell activity, but tumor-intrinsic posttranscriptional regulation driving tumor–immune cross-talk has been insufficiently defined.
- What they did: The study used two immunocompetent murine PDAC models plus spatial and flow cytometry profiling; HuR disruption was tested with T-cell depletion, and mechanisms were mapped using RNA immunoprecipitation sequencing, single-cell RNA sequencing, and in vitro/in vivo assays.
- The result: HuR stabilized mTOR pathway transcripts for metabolic adaptation, promoting tumor nutrient dominance and limiting nutrient use by neighboring tumor-reactive T cells; HuR depletion sensitized PDAC to immune checkpoint blockade and expanded tumor-specific T-cell populations.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.